chromium has been researched along with Adenocarcinoma, Clear Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bristow, RE; Diaz-Montes, TP; Giuntoli, RL; Oelke, M; Rogers, O; Webb, TJ; Zoso, A | 1 |
Clarke, NW; Dangoor, A; Gilham, DE; Griffiths, RW; Hawkins, RE; Ramani, V; Stern, PL | 1 |
2 other study(ies) available for chromium and Adenocarcinoma, Clear Cell
Article | Year |
---|---|
Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antigen-Presenting Cells; Ascites; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chromium; Cystadenocarcinoma, Serous; Cytokines; Endometrial Neoplasms; Fallopian Tube Neoplasms; Female; Flow Cytometry; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Survival Rate; T-Lymphocytes, Regulatory | 2009 |
Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antibodies, Monoclonal; Antigens, Neoplasm; Apoptosis; Carcinoma, Papillary; Carcinoma, Renal Cell; Chromium; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunotherapy; Interferon-gamma; Kidney Neoplasms; Male; Membrane Glycoproteins; Middle Aged; T-Lymphocytes | 2005 |